Saccomano Nicholas A
President and CEO
Saccomano Nicholas A has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 23, 2026.
On the most recent filing, Saccomano Nicholas A is listed as President and CEO at OnKure Therapeutics, Inc. Inside the rolling window, Saccomano Nicholas A reported no open-market purchases and 4 open-market sales totaling $1K in OKUR. The largest disclosed transaction in the window is a sale of 86 OKUR shares on Jun 22, 2026, worth $378.
Companies traded
Other insiders at OKUR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 22, 2025 | OKUR | Sale | $231 |
Frequently asked questions
How many SEC Form 4 filings has Saccomano Nicholas A made?
Saccomano Nicholas A has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Saccomano Nicholas A trade?
Saccomano Nicholas A has filed SEC Form 4 disclosures for 1 company, including OKUR.
When was Saccomano Nicholas A's most recent SEC Form 4 filing?
Saccomano Nicholas A's most recent SEC Form 4 filing on Tracefour is dated Sep 23, 2026.
What is Saccomano Nicholas A's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Saccomano Nicholas A is listed as President and CEO.
What is Saccomano Nicholas A's total buy and sell value in the current window?
Inside the rolling retention window, Saccomano Nicholas A bought $0 and sold $1K based on SEC Form 4 filings.
What was Saccomano Nicholas A's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 86 OKUR shares on 2026-06-22, worth $378, per SEC Form 4 filings.